FDA Issues Warning Letter to Everymarket for Drug Claims

Insists Everymarket’s “Vail-Bon Jie Yang Wan” and “Ossos-Sans” are unapproved new drugs.

Author Image

By: TOM BRANNA

Editor

The US Food and Drug Administration (FDA) issued a Warning Letter to Everymarket Inc., O’Fallon, MO, for making drug claims. Specifically, FDA reviewed the company’s website and charged Everymarket’s “Vail-Bon Jie Yang Wan” and “Ossos-Sans” are unapproved new drugs introduced or delivered for introduction into interstate commerce in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 355(a) and 331(d). Furthermore, Vail-Bon Jie Yang Wan i...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters